﻿<?xml version="1.0" encoding="UTF-8"?>
<ArticleSet>
  <Article>
    <Journal>
      <PublisherName>Nickan Research Institute</PublisherName>
      <JournalTitle>Immunopathologia Persa</JournalTitle>
      <Issn>2423-8015</Issn>
      <Volume>12</Volume>
      <Issue>2</Issue>
      <PubDate PubStatus="ppublish">
        <Year>2026</Year>
        <Month>07</Month>
        <DAY>01</DAY>
      </PubDate>
    </Journal>
    <ArticleTitle>The immunomodulatory effect of ivermectin on rat vasculitis model</ArticleTitle>
    <FirstPage>e42741</FirstPage>
    <LastPage>e42741</LastPage>
    <ELocationID EIdType="doi">10.34172/ipp.2026.42741</ELocationID>
    <Language>EN</Language>
    <AuthorList>
      <Author>
        <FirstName>Teeba Sarem</FirstName>
        <LastName>Sadeq</LastName>
        <Identifier Source="ORCID">https://orcid.org/0009-0003-9307-3005</Identifier>
      </Author>
      <Author>
        <FirstName>Nadia H</FirstName>
        <LastName>Mohammed</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0001-9234-3198</Identifier>
      </Author>
      <Author>
        <FirstName>Inam Sameh</FirstName>
        <LastName>Arif</LastName>
        <Identifier Source="ORCID">https://orcid.org/0000-0002-9194-1919</Identifier>
      </Author>
    </AuthorList>
    <PublicationType>Journal Article</PublicationType>
    <ArticleIdList>
      <ArticleId IdType="doi">10.34172/ipp.2026.42741</ArticleId>
    </ArticleIdList>
    <History>
      <PubDate PubStatus="received">
        <Year>2024</Year>
        <Month>08</Month>
        <Day>28</Day>
      </PubDate>
      <PubDate PubStatus="accepted">
        <Year>2024</Year>
        <Month>11</Month>
        <Day>28</Day>
      </PubDate>
    </History>
    <Abstract>Introduction: Vasculitis is the inflammation of the blood vessel walls and tissues, affecting single organs or multiple systems and is often a hidden factor in numerous disorders. Different pathogens induce innate and adaptive immune system cells to release pro-inflammatory cytokines. These processes lead to the production of proteolytic enzymes, oxidative stress, vascular homeostasis disruption, and destruction of endothelial cells. Objectives: This study aims to investigate the immunomodulatory effects of ivermectin on the rat vasculitis model. Materials and Methods: This experimental animal study included 33 male Wistar albino rats which were divided into five groups. The disease was induced in all groups except group I (control); rats of this group received the dissolving vehicles only. Group II (vasculitis induction group) received ovalbumin and lipopolysaccharide (LPS). Group III, group IV and group V (ivermectin groups) were pretreated with 0.5 mg/kg, 1 mg/kg and 1.5 mg/kg of ivermectin, respectively, for seven days, followed by vasculitis induction using ovalbumin and LPS. Results: This study showed a significant reduction (P&lt;0.001) in serum interleukin-6 (IL-6), C-reactive protein (CRP) and myeloperoxidase (MPO) anti-neutrophil cytoplasmic antibody (ANCA) levels in rats who received ivermectin compared to the disease group. Immunohistochemistry staining of Toll-like receptor 4 (TLR4) showed a decrease in the expression of this receptor in ivermectin groups. Conclusion: Ivermectin modulates inflammatory reactions by inhibiting inflammatory marker expression. Therefore, ivermectin can be effective in protecting against the disease. </Abstract>
    <ObjectList>
      <Object Type="keyword">
        <Param Name="value">Vasculitis</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Adaptive immune system</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Ivermectin</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Interleukin-6</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">C-reactive protein</Param>
      </Object>
      <Object Type="keyword">
        <Param Name="value">Myeloperoxidase ANCA</Param>
      </Object>
    </ObjectList>
  </Article>
</ArticleSet>